Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-919-1 | CAS number: -
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 30 Jul - 07 Aug 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- The analytical purity of the test substance was not reported.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted Jul 1997
- Deviations:
- yes
- Remarks:
- analytical purity of the test substance was not reported
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- yes
- Remarks:
- analytical purity of the test substance was not reported
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Direccion General de Farmacia y Productos Sanitarios, Consejera de Sanidad y Consumo, Madrid, Spain
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2-octyldodecyl myristate
- EC Number:
- 245-205-8
- EC Name:
- 2-octyldodecyl myristate
- Cas Number:
- 22766-83-2
- Molecular formula:
- C34H68O2
- IUPAC Name:
- 2-octyldodecyl myristate
- Test material form:
- liquid
Constituent 1
Method
- Target gene:
- his operon
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Metabolic activation system:
- Cofactor supplemented post-mitochondrial fraction (S9-mix), prepared from the livers of rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- 0.05, 0.15, 0.5, 1.5, 5 µL/plate, with and without metabolic activation
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: no data
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- solvent type not reported
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-nitrofluorene, sodium azide, 9-aminoacridine, 4-nitroquinoline-N-oxide, 2-aminoanthracene
- Remarks:
- See 'Any other information on material and methods incl. tables' for details on positive controls
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); if the first assay result was negative the second assay was performed as a preincubation assay, and if the first assay result was positive the second assay was performed as a plate incorporation assay
DURATION
- Preincubation period: 20 min (second assay)
- Exposure duration: 48 hrs
NUMBER OF REPLICATIONS: 3 replications in 2 independent assays
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- A test substance is considered positive (mutagenic) in the test if:
It induces a dose-resonse in the range tested and/or
a reproducible increase at one or more concentrations in the number of revertant colonies per plate in at least one strain with ot without mutagenic activation is observed. - Statistics:
- Mean values and standard deviation were calculated.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no precipitation was observed at any dose level, with and without metabolic activation.
COMPARISON WITH HISTORICAL CONTROL DATA: yes, the negative control and test substance results fell within the historical control data range (see Table 1 under 'Any other information on material and methods incl. tables').
ADDITIONAL INFORMATION ON CYTOTOXICITY: no cytotoxicity was observed up to and including the highest dose level, which is the limit dose level recommended in the OECD 471 guideline.
OTHER: Only 2-amino anthracene was used as a positive control, however, dilutions of the sample S9-mix were tested and confirmed to activate benzo(a)pyrene and 2-amino anthracene.
Any other information on results incl. tables
Table 2. Test results of experiment 1 (plate incorporation method)
With or without S9-Mix |
Test substance concentration (μL/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard deviation) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
WP2 uvR |
TA98 |
TA1537 |
||
- |
Solvent |
49.7 ± 26.1 |
14.7 ± 1.5 |
76.0 ± 8.2 |
14.7 ± 2.5 |
27.3 ± 5.5 |
- |
0.05 |
41.0 ± 4.0 |
14.7 ± 3.8 |
77.3 ± 22.9 |
21.3 ± 3.8 |
28.0 ± 8.9 |
- |
0.15 |
37.7 ± 3.8 |
11.0 ± 1.0 |
59.7 ± 7.2 |
16.0 ± 7.1 |
29.0 ± 3.0 |
- |
0.5 |
36.3 ± 6.8 |
13.3 ± 3.1 |
59.7 ± 4.9 |
20.0 ± 4.6 |
40.0 ± 21.0 |
- |
1.5 |
42.7 ± 4.7 |
12.0 ± 2.6 |
55.7 ± 21.1 |
16.3 ± 4.9 |
34.3 ± 9.6 |
- |
5.0 |
47.3 ± 10.1 |
10.3 ± 2.1 |
43.3 ± 18.1 |
17.0 ± 1.0 |
37.3 ± 8.6 |
Positive controls, –S9 |
Name |
NaN3 |
NaN3 |
4 -NNO |
2-NF |
9-AA |
Concentrations positive controls (μg/plate) |
10 |
30 |
7 |
90 |
100 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
556.3 ± 55.2 |
184.7 ± 46.8 |
610.0 ± 30.3 |
399.3 ± 25.0 |
215.0 ± 1.0 |
|
+ |
Solvent |
44.0 ± 2.0 |
15.7 ± 7.4 |
71.7 ± 14.7 |
20.3 ± 4.7 |
8.7 ± 3.1 |
+ |
0.05 |
52.0 ± 6.1 |
14.3 ± 7.8 |
90.7 ± 17.5 |
27.7 ± 1.5 |
10.0 ± 5.6 |
+ |
0.15 |
67.0 ± 14.7 |
15.3 ± 5.1 |
76.0 ± 39.9 |
27.0 ± 5.3 |
5.7 ± 2.1 |
+ |
0.5 |
47.0 ± 10.1 |
15.7 ± 3.5 |
87.3 ± 29.9 |
26.3 ± 5.0 |
8.7 ± 0.6 |
+ |
1.5 |
49.7 ± 13.3 |
10.7 ± 1.2 |
80.7 ± 24.0 |
21.7 ± 4.5 |
9.0 ± 2.6 |
+ |
5.0 |
61.3 ± 9.0 |
10.7 ± 2.5 |
64.7 ± 29.7 |
19.7 ± 4.7 |
7.0 ± 4.6 |
Positive controls, +S9 |
Name |
2-AA |
2-AA |
2-AA |
2-AA |
2-AA |
Concentrations (μL/plate) |
10 |
30 |
7 |
10 |
30 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
305.0 ± 41.6 |
326.0 ± 10.8 |
320.0 ± 6.2 |
611.3 ± 108.1 |
320.0 ± 6.2 |
|
2-NF: 2-nitrofluorene
NaN3: sodium azide
9-AA: 9-aminoacridine
4-NNO: 4-nitroquinoline-N-oxide
2-AA: 2-aminoanthracene
Table 3. Test results of experiment 2 (preincubation method)
With or without S9-Mix |
Test substance concentration (μL/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard Deviation ) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
WP2 uvR |
TA98 |
TA1537 |
||
- |
Solvent |
64.3 ± 5.1 |
9.7 ± 5.5 |
74.7 ± 19.0 |
22.7 ± 6.5 |
9.7 ± 3.2 |
- |
0.05 |
39.0 ± 1.0 |
12.3 ± 5.8 |
113.0 ± 15.7 |
23.3 ± 3.1 |
11.3 ± 3.1 |
- |
0.15 |
44.3 ± 4.2 |
12.3 ± 5.0 |
103.7 ± 17.6 |
24.0 ± 2.0 |
11.0 ± 3.5 |
- |
0.5 |
38.7 ± 14.2 |
9.0 ± 6.9 |
116.3 ± 10.8 |
22.7 ± 2.1 |
10.7 ± 1.5 |
- |
1.5 |
34.0 ± 3.0 |
16.7 ± 4.9 |
107.3 ± 10.1 |
29.3 ± 7.6 |
11.7 ± 5.5 |
- |
5.0 |
43.3 ± 10.7 |
10.0 ± 2.6 |
116.7 ± 10.1 |
19.3 ± 9.9 |
11.0 ± 5.2 |
Positive controls, –S9 |
Name |
NaN3 |
NaN3 |
4-NNO |
2-NF |
9-AA |
Concentrations (μL/plate) |
10 |
30 |
7 |
90 |
100 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
580.0 ± 8.2 |
504.0 ± 27.6 |
810.0 ± 77.3 |
544.3 ± 417.5 |
682.7 ± 91.5 |
|
+ |
Solvent |
47.0 ± 9.8 |
17.7 ± 5.5 |
45.3 ± 5.9 |
15.0 ± 4.0 |
19.3 ± 9.1 |
+ |
0.05 |
52.0 ± 6.6 |
18.0 ± 3.0 |
74.0 ± 5.6 |
17.3 ± 3.8 |
25.7 ± 1.5 |
+ |
0.15 |
51.3 ± 9.0 |
13.0 ± 7.9 |
80.0 ± 6.1 |
18.0 ± 4.4 |
24.7 ± 8.7 |
+ |
0.5 |
58.7 ± 8.5 |
16.0 ± 5.0 |
63.7 ± 14.5 |
17.7 ± 1.5 |
18.7 ± 3.1 |
+ |
1.5 |
58.7 ± 4.2 |
19.0 ± 6.2 |
76.0 ± 18.0 |
14.0 ± 3.6 |
18.3 ± 6.0 |
+ |
5.0 |
56.3 ± 4.1 |
15.7 ± 3.1 |
78.7 ± 26.1 |
16.0 ± 4.4 |
32.0 ± 6.9 |
Positive controls, +S9 |
Name |
2-AA |
2-AA |
2-AA |
2-AA |
2-AA |
Concentrations (μL/plate) |
10 |
30 |
7 |
10 |
30 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
352.7 ± 62.0 |
284.7 ± 11.7 |
475.7 ± 84.4 |
299.7 ± 79.6 |
161.7 ± 27.5 |
|
2-NF: 2-nitrofluorene
NaN3: sodium azide
9-AA: 9-aminoacridine
4-NNO: 4-nitroquinoline-N-oxide
2 -AA: 2 -aminoanthracene
Applicant's summary and conclusion
- Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
